Prof. Jorge Contreras

Professor of Law, University of Utah College of Law

Jorge L. Contreras teaches in the areas of intellectual property, law and science, and property law. He serves on the Scientific Advisory Board of the Utah Genome Project.

Professor Contreras has previously served on the law faculties of American University Washington College of Law and Washington University in St. Louis, and was a partner at the international law firm Wilmer Cutler Pickering Hale and Dorr LLP, where he practiced transactional and intellectual property law in Boston, London and Washington DC.

Professor Contreras’s current research focuses, among other things, on the development of technical standards and the use and dissemination of data generated by large-scale scientific research projects. His published work has appeared in scientific, legal and policy journals including Science, Nature Biotechnology, Georgetown Law Journal, Arizona State Law Journal, North Carolina Law Review, Florida State Law ReviewJurimetrics, American University Law Review, Harvard Journal of Law and Technology, Berkeley Technology Law Journal, Antitrust Law Journal, Santa Clara Law Review and Utah Law Review. He recently co-edited the book Patent Pledges: Global Perspectives on Patent Law's Private Ordering Frontier (Edward Elgar 2017) and has been quoted in the New York Times, Wall Street Journal, Economist, Bloomberg, Washington Post, Korea Times and other national and international media outlets.

Professor Contreras serves Co-Chair of the Interdisciplinary Division of the ABA’s Section of Science & Technology Law, a member of the National Institutes of Health (NIH) Council of Councils, and the Intellectual Property Rights Policy Committee of the American National Standards Institute (ANSI).  He has recently served as Co-Chair of the National Conference of Lawyers and Scientists, a member of the National Academy of Sciences (NAS) Committee on Intellectual Property Management in Standard-Setting Processes, the Advisory Council of NIH's National Center for the Advancement of Translational Sciences (NCATS), the Cures Acceleration Network (CAN) Board and the National Advisory Council for Human Genome Research. 

He is a cum laude graduate of Harvard Law School (JD) and Rice University (BA, BSEE) and clerked for Chief Justice Thomas R. Philips of the Texas Supreme Court. 

*****

A person listed as a contributor has spoken or otherwise participated in Federalist Society events, publications, or multimedia presentations. A person's appearance on this list does not imply any other endorsement or relationship between the person and the Federalist Society. In most cases, the biographical information on a person's "contributor" page is provided directly by the person, and the Federalist Society does not edit or otherwise endorse that information. The Federalist Society takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.

The EU’s Proposed Regulations of SEP Licensing and Litigation: A Solution or Setback for the Global Innovation Economy?

The EU’s Proposed Regulations of SEP Licensing and Litigation: A Solution or Setback for the Global Innovation Economy?

A Regulatory Transparency Project Webinar

The European Union is considering adopting a wide-ranging regulatory regime for the licensing and litigation...

Click to play: The EU’s Proposed Regulations of SEP Licensing and Litigation: A Solution or Setback for the Global Innovation Economy?

The EU’s Proposed Regulations of SEP Licensing and Litigation: A Solution or Setback for the Global Innovation Economy?

A Regulatory Transparency Project Webinar

The European Union is considering adopting a wide-ranging regulatory regime for the licensing and litigation...

Covid-19 Vaccines and Intellectual Property

Covid-19 Vaccines and Intellectual Property

Practice Groups Teleforum

In October 2020, two countries, India and South Africa, that had been hit particularly hard...

Click to play: Covid-19 Vaccines and Intellectual Property

Covid-19 Vaccines and Intellectual Property

Practice Groups Teleforum

In October 2020, two countries, India and South Africa, that had been hit particularly hard...